Arkolith/Insider Trading/JAZZ/Form 4

Pearce Samantha

EVP, Chief Commercial OfficerJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Jun 1, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2026Option exercise(M)7K$109.45$756K57K
May 28, 2026Sell(S)7K$235.41$1.6M50K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2026Option exercise(M)7K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001805688-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML